Evidence map›Paper›PMID 17614212›Full record

ArticleNeuroscience2007

Calcitonin receptor-like receptor and receptor activity modifying protein 1 in the rat dorsal horn: localization in glutamatergic presynaptic terminals containing opioids and adrenergic alpha2C receptors.

J C G Marvizón, O A Pérez, B Song, W Chen, N W Bunnett, E F Grady, A J Todd

Abstract read
In one paragraph

Article in Neuroscience, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Article
  3. Pathology of pain and its implications for therapeutic interventions.Signal transduction and targeted therapy · 2024
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Cross-talk signaling in the trigeminal ganglion: role of neuropeptides and other mediators.Journal of neural transmission (Vienna, Austria : 1996) · 2020
    Review
  9. The role of erenumab in the treatment of migraine.Therapeutic advances in neurological disorders · 2020
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Calcitonin gene-related peptide (CGRP): a new target for migraine.Annual review of pharmacology and toxicology · 2015
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

J C G MarvizónCenter for Neurovisceral Sciences and Women's Health and CURE: Department of Medicine, David Geffen School of Medicine at UCLA and Veteran Affairs Greater Los Angeles Healthcare System, Los Angeles, CA 90073, USA. marvizon@ucla.edu
O A Pérez
B Song
W Chen
N W Bunnett
E F Grady
A J Todd
VA Greater Los Angeles Healthcare System · USUniversity of California, San Francisco · USUniversity of California, Los Angeles · USUniversity of Glasgow · GB

Funding

Spinal Opioid Release in NociceptionR01DA012609 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MARVIZON, JUAN CARLOS GARCIA · 2000 to 2008
$2.2M
NIDA NIH HHS 2-R01-DA012609NIDA NIH HHS R01 DA012609Wellcome Trust 076976
6 · The paper itself

Abstract

Calcitonin gene-related peptide (CGRP) is abundant in the central terminals of primary afferents. However, the function of CGRP receptors in the spinal cord remains unclear. CGRP receptors are heterodimers of calcitonin receptor-like receptor (CRLR) and receptor activity modifying protein 1 (RAMP1). We studied the localization of CRLR and RAMP1 in the rat dorsal horn using well-characterized antibodies against them, which labeled numerous puncta in laminae I-II. In addition, RAMP1 was found in cell bodies, forming patches at the cell surface. The CRLR- and RAMP1-immunoreactive puncta were further characterized using double and triple labeling. Colocalization was quantified in confocal stacks using Imaris software. CRLR did not colocalize with primary afferent markers, indicating that these puncta were not primary afferent terminals. CRLR- and RAMP1-immunoreactive puncta contained synaptophysin and vesicular glutamate transporter-2 (VGLUT2), showing that they were glutamatergic presynaptic terminals. Electron microscopic immunohistochemistry confirmed that CRLR immunoreactivity was present in axonal boutons that were not in synaptic glomeruli. Using tyramide signal amplification for double labeling with the CRLR and RAMP1 antibodies, we found some clear instances of colocalization of CRLR with RAMP1 in puncta, but their overall colocalization was low. In particular, CRLR was absent from RAMP1-containing cells. Many of the puncta stained for CRLR and RAMP1 were labeled by anti-opioid and anti-enkephalin antibodies. CRLR and, to a lesser extent, RAMP1 also colocalized with adrenergic alpha(2C) receptors. Triple label studies demonstrated three-way colocalization of CRLR-VGLUT2-synaptophysin, CRLR-VGLUT2-opioids, and CRLR-opioids-alpha(2C) receptors. In conclusion, CRLR is located in glutamatergic presynaptic terminals in the dorsal horn that contain alpha(2C) adrenergic receptors and opioids. Some of these terminals contain RAMP1, which may form CGRP receptors with CRLR, but in others CRLR may form other receptors, possibly by dimerizing with RAMP2 or RAMP3. These findings suggest that CGRP or adrenomedullin receptors modulate opioid release in the dorsal horn.

Indexed as

Afferent PathwaysAnalgesics, OpioidAnimalsBiomarkersCalcitonin Gene-Related PeptideCalcitonin Receptor-Like ProteinGlutamic AcidImmunohistochemistryIntracellular Signaling Peptides and ProteinsMaleMembrane ProteinsMicroscopy, Electron, TransmissionMicroscopy, ImmunoelectronNociceptorsPosterior Horn CellsPresynaptic TerminalsAdra2c protein, ratAnalgesics, OpioidBiomarkersCalcitonin Gene-Related PeptideCalcitonin Receptor-Like ProteinCalcrl protein, ratGlutamic AcidIntracellular Signaling Peptides and ProteinsMembrane ProteinsRamp1 protein, ratRamp2 protein, ratRamp3 protein, ratReceptor Activity-Modifying Protein 1Receptor Activity-Modifying Protein 2Receptor Activity-Modifying Protein 3Receptor Activity-Modifying ProteinsReceptors, Adrenergic, alpha-2Receptors, CalcitoninSlc17a6 protein, ratSynaptophysinVesicular Glutamate Transport Protein 2

Identifiers

PMID17614212
PMCPMC2329818
OpenAlexW1977067039

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.